Sanmeds offers Cazanat 60 at just ₹7,800 – the lowest price in India!

Abiraterone acetate (Cazanat) delivers potent CYP17A1 inhibition for hormone-sensitive and castration-resistant prostate cancer management. Urologic oncologists employ this agent in combination with prednisone to prevent androgen biosynthesis and manage mineralocorticoid excess. Treatment protocols mandate regular blood pressure monitoring, electrolyte assessment including potassium surveillance, and testosterone suppression verification through quarterly laboratory studies. Patients receiving abiraterone therapy must maintain strict medication adherence with food requirements, communicate any symptoms of hypokalemia or fluid retention to their medical team, and participate in ongoing surveillance for treatment efficacy and toxicity management.